Neoadjuvant Programmed Cell Death 1 (PD-1) Inhibitor Treatment in Patients With Hepatocellular Carcinoma Before Liver Transplant: A Cohort Study and Literature Review

Programmed cell death 1 (PD-1) blockade is considered contraindicated in liver transplant (LT) recipients due to potentially lethal consequences of graft rejection and loss. Though post-transplant PD-1 blockade had already been reported, pre-transplant use of PD-1 blockade has not been thoroughly in...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiao, Zi-yun, Zhang, Zi-jie, Lv, Zi-cheng, Tong, Huan, Xi, Zhi-feng, Wu, Hao-xiang, Chen, Xiao-song, Xia, Lei, Feng, Hao, Zhang, Jian-jun, Xia, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326904/
https://www.ncbi.nlm.nih.gov/pubmed/34349755
http://dx.doi.org/10.3389/fimmu.2021.653437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326904/
https://www.ncbi.nlm.nih.gov/pubmed/34349755
http://dx.doi.org/10.3389/fimmu.2021.653437

Ejemplares similares